Cellectar Biosciences, Inc. Recorded Big Gain
Wed, Jun 04, 2025 at 07:44 PM
Cellectar Biosciences, Inc. (CLRB:NASDAQ) shot up at $0.46, representing a gain of 66.3%. On Wed, Jun 04, 2025, CLRB:NASDAQ touched a New 2-Week High of $0.46. The stock appeared on our News Catalysts scanner on Wed, Jun 04, 2025 at 01:03 PM in the 'BIOTECH' category. From Wed, May 21, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Jun 04, 2025 at $0.69 with a volume of 616M+.
About Cellectar Biosciences, Inc. (CLRB:NASDAQ)
Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 225%
- K Wave Media Ltd. (KWM:NASDAQ), 133.33%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 132.78%
- Latch, Inc. (LTCH:NASDAQ), 75%
- Nano Labs Ltd (NA:NASDAQ), 71.24%
- Sharps Technology, Inc. (STSS:NASDAQ), 68.72%
- Lyell Immunopharma, Inc. (LYEL:NASDAQ), 68.59%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 66.36%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 66.32%
- mF International Limited (MFI:NASDAQ), 60.83%